These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 20708973

  • 1. Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics.
    Wullner D, Zhou L, Bramhall E, Kuck A, Goletz TJ, Swanson S, Chirmule N, Jawa V.
    Clin Immunol; 2010 Oct; 137(1):5-14. PubMed ID: 20708973
    [Abstract] [Full Text] [Related]

  • 2. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y, Yamaguchi Y, Ohshita A, Minami K, Toge T.
    Anticancer Res; 2004 Oct; 24(2C):1193-200. PubMed ID: 15154646
    [Abstract] [Full Text] [Related]

  • 3. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M.
    J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135
    [Abstract] [Full Text] [Related]

  • 4. Human gammadelta T cells modulate the mite allergen-specific T-helper type 2-skewed immunity.
    Korematsu S, Tanaka Y, Nagakura T, Minato N, Izumi T.
    Clin Exp Allergy; 2007 Nov 30; 37(11):1681-7. PubMed ID: 17883427
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N, Sanjoh K, Yokoyama S, Hayashi T.
    J Immunol; 1987 Nov 15; 139(10):3281-6. PubMed ID: 3500214
    [Abstract] [Full Text] [Related]

  • 6. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M, Piovesan P, Ghirardi O, Mastroianni D, Bombardi V, Battistini L, Cencioni MT, Capobianco D, Borsini F, Colombo M, Verdoliva A.
    Mol Immunol; 2009 Aug 15; 46(13):2524-32. PubMed ID: 19535144
    [Abstract] [Full Text] [Related]

  • 7. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ, Leenaars MP, Guzylack-Piriou L, Summerfield A, Hendriksen CF, McCullough KC.
    Vaccine; 2006 Apr 12; 24(16):3076-83. PubMed ID: 16504349
    [Abstract] [Full Text] [Related]

  • 8. Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
    de Jong A, van der Burg SH, Kwappenberg KM, van der Hulst JM, Franken KL, Geluk A, van Meijgaarden KE, Drijfhout JW, Kenter G, Vermeij P, Melief CJ, Offringa R.
    Cancer Res; 2002 Jan 15; 62(2):472-9. PubMed ID: 11809698
    [Abstract] [Full Text] [Related]

  • 9. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 15; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 10. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects.
    Mustafa AS.
    Med Princ Pract; 2009 Jun 15; 18(5):385-92. PubMed ID: 19648762
    [Abstract] [Full Text] [Related]

  • 11. Analysis of antigen-specific T-cell responses with synthetic peptides--what kind of peptide for which purpose?
    Kiecker F, Streitz M, Ay B, Cherepnev G, Volk HD, Volkmer-Engert R, Kern F.
    Hum Immunol; 2004 May 15; 65(5):523-36. PubMed ID: 15172453
    [Abstract] [Full Text] [Related]

  • 12. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C, Troye-Blomberg M, Deloron P, Kabilan L, Lepers JP, Savel J, Perlmann P.
    J Immunol; 1991 Oct 01; 147(7):2295-301. PubMed ID: 1717554
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
    Clin Immunol; 2007 Jan 01; 122(1):75-84. PubMed ID: 17045846
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D.
    Clin Cancer Res; 2009 Jul 01; 15(13):4467-74. PubMed ID: 19531622
    [Abstract] [Full Text] [Related]

  • 15. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.
    Barratt-Boyes SM, Vlad A, Finn OJ.
    Clin Cancer Res; 1999 Jul 01; 5(7):1918-24. PubMed ID: 10430099
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J, Minato N, Kano S.
    J Clin Invest; 1986 May 01; 77(5):1596-605. PubMed ID: 3084562
    [Abstract] [Full Text] [Related]

  • 17. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H, Nagato T, Takahara M, Sato K, Kimura S, Aoki N, Azumi M, Tateno M, Harabuchi Y, Celis E.
    Cancer Res; 2008 Feb 01; 68(3):901-8. PubMed ID: 18245493
    [Abstract] [Full Text] [Related]

  • 18. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
    UytdeHaag F, Claassen I, Bunschoten H, Loggen H, Ottenhoff T, Teeuwsen V, Osterhaus A.
    J Mol Cell Immunol; 1987 Feb 01; 3(3):145-55. PubMed ID: 2908179
    [Abstract] [Full Text] [Related]

  • 19. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
    Löhr HF, Schlaak JF, Lohse AW, Böcher WO, Arenz M, Gerken G, Meyer Zum Büschenfelde KH.
    Hepatology; 1996 Dec 01; 24(6):1416-21. PubMed ID: 8938173
    [Abstract] [Full Text] [Related]

  • 20. Impaired T cell proliferation in acute dengue infection.
    Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL.
    J Immunol; 1999 May 01; 162(9):5609-15. PubMed ID: 10228044
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.